Blog

Photo taken from Zhen Su/LinkedIn

Apr 9, 2024, 15:02

Zhen Su: Really excited to see Pfizer leadership donated Bavencio US sales loyalty to American Association for Cancer Research

Zhen Su, CEO at Marengo Therapeutics, recently posted on LinkedIn:

“Really excited to see Pfizer leadership donated Bavencio US sales loyalty to American Association for Cancer Research to fund next-wave oncology innovation. A shoutout to Albert Bourla Chris Boshoff, and Mikael Dolsten for this transformative contribution to the cancer research community!
We are proud of the Merck Group and Pfizer Bavencio alliances and everyone who has contributed to this important partnership especially the early clinical trial investigators at the National Cancer Institute (NCI) led by Dr. James Gulley.”

Source: Zhen Su/LinkedIn

AACR Albert Bourla Chris Boshoff cancer Cancer research James Gulley Medical Partnership Merck Group Mikael Dolsten National Cancer Institute NCI OncoDaily Oncology Oncology Innovation pfizer Pfizer Bavencio

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage